Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Obesity × Dalteparin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Classical hematology 1

Conditions

Venous Thromboembolism 12 Venous Thrombosis 9 Neoplasms 9 Pulmonary Embolism 7 Thromboembolism 4 Thrombosis 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Lung Neoplasms 3 Neoplasm Metastasis 2 Lymphoma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Ovarian Neoplasms 1 Obesity 1 Neoplasms, Plasma Cell 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Monoclonal Gammopathy of Undetermined Significance 1

Interventions

Exercise 21 Metformin 18 Methods 7 Diet Therapy 7 Diet 7 Tirzepatide 6 Nutrition Assessment 6 Early Intervention, Educational 6 Counseling 6 Caloric Restriction 6 Resistance Training 5 Exenatide 5 Educational Status 4 Docosahexaenoic Acids 4 Diet, Mediterranean 4 semaglutide 3 Vitamin D 3 Standard of Care 3 Liraglutide 3 Dexamethasone 3 Yoga 2 Therapeutics 2 Tablets 2 Surveys and Questionnaires 2 Sugars 2 Specimen Handling 2 Ovidrel 2 Nutritional Status 2 Naltrexone 2 Hydrocortisone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297359 2024-01-23

WAVe

Ottawa Hospital Research Institute

Phase 2 Terminated

Classical hematologyOther

Neoplasms, Obesity, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡